CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-28 | Simon Barry J. See remarks | Sale | −11,304 | $20.53 | $232K | 3,170,540 |
| 2021-01-28 | Simon Barry J. See remarks | Option exercise · Stock Option (right to buy) | −11,304 | 214,190 | ||
| 2021-01-27 | Simon Barry J. See remarks | Option exercise | +36,626 | $2.00 | $73K | 3,207,166 |
| 2021-01-27 | Simon Barry J. See remarks | Sale | −36,626 | $20.61 | $755K | 3,170,540 |
| 2021-01-27 | Simon Barry J. See remarks | Option exercise · Stock Option (right to buy) | −36,626 | 225,494 | ||
| 2021-01-12 | Nelson Sonja Chief Financial Officer | Option exercise | +11,364 | $3.07 | $35K | 31,774 |
| 2021-01-12 | Nelson Sonja Chief Financial Officer | Sale | −16,364 | $15.00 | $245K | 15,410 |
| 2021-01-12 | Nelson Sonja Chief Financial Officer | Option exercise · Stock Option (right to buy) | −11,364 | 165,907 | ||
| 2021-01-04 | Nelson Sonja Chief Financial Officer | Option exercise | +22,729 | $3.07 | $70K | 59,681 |
| 2021-01-04 | Nelson Sonja Chief Financial Officer | Sale | −39,271 | $13.62 | $535K | 20,410 |
| 2021-01-04 | Nelson Sonja Chief Financial Officer | Option exercise · Stock Option (right to buy) | −22,729 | 177,271 | ||
| 2020-12-22 | Simon Barry J. See remarks | Option exercise | +130,000 | $2.00 | $260K | 3,300,540 |
| 2020-12-22 | Simon Barry J. See remarks | Sale | −130,000 | $18.05 | $2.3M | 3,170,540 |
| 2020-12-22 | Simon Barry J. See remarks | Option exercise · Stock Option (right to buy) | −130,000 | 262,120 | ||
| 2020-12-10 | Thomas John C Director | Sale | −42,592 | $10.83 | $461K | 207,477 |
| 2020-08-19 | Thomas John C Director | Sale | −20,000 | $9.19 | $184K | 250,069 |
| 2020-08-13 | Thomas John C Director | Sale | −20,000 | $9.49 | $190K | 290,069 |
| 2020-08-13 | Thomas John C Director | Sale | −20,000 | $9.34 | $187K | 270,069 |
| 2020-08-11 | Thomas John C Director | Sale | −19,790 | $10.35 | $205K | 310,279 |
| 2020-08-11 | Thomas John C Director | Sale | −210 | $10.55 | $2K | 310,069 |
Page 15 of 22 · 433 trades